We are live on ! Find out more
CI

CPMG Inc Portfolio holdings

AUM $37.1M
1-Year Est. Return 74.35%
This Fund
S&P 500
This Quarter Est. Return
-29.64%
1 Year Est. Return
+74.35%
3 Year Est. Return
+878.37%
5 Year Est. Return
+1,872.39%
10 Year Est. Return
AUM
$542M
AUM Growth
-$365M
Cap. Flow
+$5.95M
Cap. Flow %
1.1%
Top 10 Hldgs %
100%
Holding
5
New
Increased
1
Reduced
1
Closed

Top Sells

1
QQQ icon
Invesco QQQ Trust
QQQ
+$20.8K

Sector Composition

1 Healthcare 98.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRCT icon
1
Procept Biorobotics
PRCT
$1.09B
$281M 51.76%
11,222,662
TIL icon
2
Instil Bio
TIL
$50.9M
$145M 26.75%
423,940
RETA
3
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$76.4M 14.09%
2,896,901
APEN
4
DELISTED
Apollo Endosurgery, Inc.
APEN
$32.7M 6.03%
3,878,742
+683,871
+21% +$5.97M
QQQ icon
5
Invesco QQQ Trust
QQQ
$466B
$7.44M 1.37%
18,704
-54
-0.3% -$20.8K

Similar funds

CPMG Inc's Q4 2021 Portfolio in Review

As of Q4 2021, CPMG Inc held 5 positions worth $542M, down 40% from $907M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2021: portfolio turnover was 0%. CPMG Inc opened no new positions and made no exits, leaving the 5-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, down from 99% a quarter earlier.

  • CPMG Inc added most to Apollo Endosurgery, Inc. in Q4 2021, an estimated $5.97M increase.
  • CPMG Inc's biggest Q4 2021 reduction was Invesco QQQ Trust, cutting an estimated $20.8K.
  • CPMG Inc's ten largest holdings make up 100% of its $542M portfolio in Q4 2021.
  • CPMG Inc opened 0 new positions and closed 0 in Q4 2021.
  • CPMG Inc's portfolio value fell 40% quarter-over-quarter to $542M.

Based on CPMG Inc's 13F filing for Q4 2021, filed 14 Feb 2022.